Metastasiertes Nierenzellkarzinom: Nephrektomie plus Sunitinib versus Sunitinib
- PMID: 30897629
- DOI: 10.1055/a-0641-6565
Metastasiertes Nierenzellkarzinom: Nephrektomie plus Sunitinib versus Sunitinib
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Clinical Trial.
Similar articles
-
Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.J Urol. 2019 Mar;201(3):453-454. doi: 10.1016/j.juro.2018.09.050. J Urol. 2019. PMID: 30266335 No abstract available.
-
Re: Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma.Eur Urol. 2019 May;75(5):876-877. doi: 10.1016/j.eururo.2019.02.018. Epub 2019 Feb 28. Eur Urol. 2019. PMID: 30826222 No abstract available.
-
Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.Eur Urol. 2018 Jul;74(1):119-121. doi: 10.1016/j.eururo.2018.01.036. Epub 2018 Feb 9. Eur Urol. 2018. PMID: 29433972 No abstract available.
-
Sunitinib therapy in renal cell carcinoma.BJU Int. 2008 Jun;101(11):1339-42. doi: 10.1111/j.1464-410X.2008.07506.x. Epub 2008 Feb 18. BJU Int. 2008. PMID: 18284408 Review. No abstract available.
-
Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.Urol Int. 2009;83(1):122-4. doi: 10.1159/000224882. Epub 2009 Jul 27. Urol Int. 2009. PMID: 19641373 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical